An open-end fund is a diversified portfolio of pooled investor money that can issue an unlimited number of shares. The fund sponsor sells shares directly to investors and redeems them as well. These shares are priced daily based on their current net asset value (NAV).

Are CEFs a good investment?

Generally speaking, investing in closed-end funds offers much higher income potential but can result in significant price volatility, lower total returns, less predictable dividend growth, and the potential for more surprises.

Are CEF better than ETF?

CEFs are actively managed, whereas most ETFs are designed to track an index’s performance. CEFs achieve leverage through issuance of debt and preferred shares, as well as through financial engineering. ETFs are structured to shield investors from capital gains better than CEFs or open-end funds are.

Do CEFs pay dividends?

CEFs have distributions, not yields or dividends: A CEF portfolio’s yield may contribute to the distribution.

When to sell a closed end fund ( CEF )?

Therefore, they might drive the share price much higher than the fund’s NAV. Likewise, if a CEF is under-performing lately (even if it’s well-managed and the sector the CEF focuses on happens to be in a downtrend), investors may want out, and are willing to sell the shares at a price far below the fund’s NAV.

How is a CEF like a mutual fund?

That’s too bad, because CEFs really are quite simple: they’re like mutual funds or ETFs in that they pool money from investors, which the fund’s managers then use to buy a basket of stocks, bonds, real estate investment trusts (REITs) or other investments, depending on the CEF’s mandate.

How are CEF shares traded after the IPO?

After the IPO, a CEF’s shares trade on the open market, typically on an exchange, and the market itself determines the share price. The result is that the share price typically does not match the net asset value of the fund’s underlying holdings.

Are there any CEFs that pay 8% dividend?

The fund hands out a huge 8.6% dividend as I write this and holds a lot of familiar names in the drug business, like Amgen (AMGN), Gilead Sciences (GILD) and COVID-19 vaccine maker Moderna (MRNA). Normally, if you bought these stocks on an exchange, you’d have to pay the market price.